Antibody

COVID-19 infection will provide some immunity for at least 5 months, study finds – Health

Celltrion antibody COVID-19 improves results in phase 2

New technology could protect against various coronavirus changes

Antigenic supersite may improve COVID-19 vaccine design

OXGENE introduces an SLIM platform for the detection of antibodies against organ proteins

Exposure to SARS-CoV-2 in England may be a double report of seroprevalence

Study supports ongoing phase 3 testing of the Ad26.COV2.S SARS-CoV-2 vaccine

Researchers receive an NIH grant to develop more effective flu vaccines

MD Anderson and Xencor to develop a novel therapeutic treatment for the treatment of cancer patients

CytoDel successfully delivers neuronal antibody delivery in animal models of botulism